Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Sedation in Hysteroscopy
NCT06187896Recruiting
- Sponsor
- Renji Hospital
- Start
- Jan 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam (2 arms), sponsored by Renji Hospital. Primary endpoint: The incidence of severe hypoxia at 2 hours. Started Jan 2024; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT06187896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06187896.